Rituximab in Idiopathic Membranous Nephropathy

Selective depletion of B cells with the mAb rituximab may benefit the autoimmune glomerular disease idiopathic membranous nephropathy (IMN). Here, we describe our experience treating 100 consecutive IMN patients with persistent nephrotic syndrome with rituximab. We defined complete remission as pers...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ruggenenti, Piero, Cravedi, Paolo, Chianca, Antonietta, Perna, Annalisa, Ruggiero, Barbara, Gaspari, Flavio, Rambaldi, Alessandro, Marasà, Maddalena, Remuzzi, Giuseppe
Format: Artigo
Idioma:Inglês
Publicat: American Society of Nephrology 2012
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3402291/
https://ncbi.nlm.nih.gov/pubmed/22822077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2012020181
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars